MetGen

MetGen is a Finnish biotechnology company specializing in the development of high-performance industrial enzymes for the circular bio-economy. The company leverages its proprietary MetZyme® platform to engineer tailored enzymes that can withstand the harsh conditions of industrial processes, such as extreme pH and temperature. A primary focus of MetGen is the valorization of lignin through its SuniLign® technology, which converts this abundant wood-based byproduct into high-value bio-based chemicals and materials. Their solutions serve diverse sectors, including pulp and paper, biofuels, and wastewater treatment, aiming to reduce energy and chemical consumption. In 2022, the company was acquired by a consortium led by HydrogenOne Capital Growth to accelerate its international expansion and industrial scale-up.